Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

350
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
350
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

963
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
963
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

624
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
624
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

171
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
171

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ABCA8 drives bone loss via disrupting Th17/Treg imbalance: a novel immunometabolic target for osteoporosis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Genomic characterization of vancomycin-resistant <i>Enterococcus faecium</i> and van-carrying mobile genetic elements in a tertiary hospital in northeastern China.

Frontiers in microbiology·2026
Same author

Pan-genome insights into type VI secretion systems and their functional repertoires in <i>Enterobacter</i>.

mSystems·2026
Same author

A bed nucleus of stria terminalis neuronal ensemble mediates inflammation-induced sleep alterations in male mice.

Brain, behavior, and immunity·2026
Same author

Hyperoside impairs mitochondrial respiration in chronic myeloid leukemia by promoting STUB1-mediated ubiquitination and degradation of NOX4.

Toxicology and applied pharmacology·2026
Same author

Lactylation-Driven Macrophage Polarisation Regulates Pulp Inflammation.

International endodontic journal·2026

Related Experiment Video

Updated: Aug 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Identification of Drug-Disease Associations Using a Random Walk with Restart Method and Supervised Learning.

Xiaoqing Liu1, Wenjing Yi2, Baohang Xi2

  • 1College of Sciences, Hangzhou Dianzi University, Hangzhou 310018, China.

Computational and Mathematical Methods in Medicine
|October 20, 2022
PubMed
Summary

This study introduces a novel computational method to identify drug-disease correlations, achieving 82.7% accuracy. The approach uncovered new potential drug-disease links, including promising findings for Parkinson's disease treatments.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Related Experiment Videos

Last Updated: Aug 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Area of Science:

  • Computational biology
  • Pharmacogenomics
  • Network medicine

Background:

  • Drug-disease correlations are crucial for understanding disease mechanisms and drug repositioning.
  • Existing computational methods often use limited network information and underutilize known drug-disease association data.

Purpose of the Study:

  • To develop an integrated network approach combining random walk and supervised learning for improved drug-disease correlation prediction.
  • To leverage known drug-disease associations to guide the random walk process and enhance model accuracy.

Main Methods:

  • Designed a hybrid algorithm integrating random walk with supervised learning.
  • Utilized an integrated network to update the predictive model.
  • Initiated the random walk using gene sets derived from known drug-disease correlations.

Main Results:

  • The proposed method achieved a prediction accuracy of 82.7% in identifying drug-disease correlations.
  • Discovered 8 novel drug-disease relationships, with 5 showing potential pharmacodynamic effects on Parkinson's disease.
  • Identified a significant link between Parkinson's disease and phenylhexol, highlighting its potential role in treating alpha-synuclein and tau protein pathology.

Conclusions:

  • The developed algorithm effectively predicts drug-disease associations using integrated networks and known data.
  • The findings offer novel therapeutic insights for Parkinson's disease and demonstrate the utility of the method for drug repositioning.